- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01828580
Safety and Performance Evaluation of the AutoLap System
30 december 2014 uppdaterad av: M.S.T. Medical Surgery Technology LTD.
Safety and Performance Evaluation of the AutoLap System - a Feasibility Study
The main objectives of this study are to evaluate the safety and performance of the AutoLap system in Laparoscopic Cholecystectomy procedures.
Studieöversikt
Status
Avslutad
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Faktisk)
36
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
-
Tel Aviv, Israel, 69710
- Assuta Medical Center
-
-
-
-
-
Milano, Italien, 20162
- Niguarda Ca Granda Hospital
-
-
-
-
-
Amersfoort, Nederländerna, 3800BM
- Meander Medisch Centrum
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år till 75 år (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- Signed and dated Informed Consent Form.
- Patients between 18 and 75 years of age inclusive who were scheduled for elective laparoscopic Cholecystectomy procedure.
Exclusion Criteria:
- Previous upper abdominal surgery and contraindications to Pneumoperitoneum.
- Pregnancy.
- Obesity (BMI >35 Kg/m2).
- Generalized peritonitis.
- Septic shock from cholangitis.
- Severe acute pancreatitis.
- Uncorrected coagulopathy.
- Previous abdominal operations which prevent safe abdominal access or progression of the procedure.
- Advanced cirrhosis with failure of hepatic function.
- Suspected gallbladder cancer.
- Acute cholecystitis
- Presence of any medical or psychiatric condition or any other condition that, in the opinion of the Investigator, could affect the successful participation of the patient in the study.
- Patient participates in any other clinical study 60 days prior to the start of the study and throughout the study duration.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: AutoLap
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Adverse events
Tidsram: participants will be followed for the duration of hospital stay, an expected average of 1-2 days
|
No conversion to open surgery from laparoscopic surgery due to using the AutoLap system 2) No AutoLap system related operative complications, that require further clinical intervention
|
participants will be followed for the duration of hospital stay, an expected average of 1-2 days
|
|
Performance evaluation
Tidsram: during surgery -defined as the time from the first abdominal incision until the surgical procedure is completed (skin incisions are closed).
|
The ability of the AutoLap system to successfully move the laparoscope to the surgeon's desired position
|
during surgery -defined as the time from the first abdominal incision until the surgical procedure is completed (skin incisions are closed).
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
system set-up time
Tidsram: during surgery - defined as the time from the first abdominal incision until the surgical procedure is completed (skin incisions are closed).
|
defined as the time required from connecting the AutoLap's ARM to the bed rail
|
during surgery - defined as the time from the first abdominal incision until the surgical procedure is completed (skin incisions are closed).
|
|
Average total procedure time
Tidsram: during surgery - defined as the time from the first abdominal incision until the surgical procedure is completed (skin incisions are closed).
|
defined as the time from first abdominal incision until the surgical procedure is completed
|
during surgery - defined as the time from the first abdominal incision until the surgical procedure is completed (skin incisions are closed).
|
|
Number of times that the laparoscope was removed for cleaning
Tidsram: During surgery - defined as the time from the first abdominal incision until the surgical procedure is completed (skin incisions are closed).
|
During surgery - defined as the time from the first abdominal incision until the surgical procedure is completed (skin incisions are closed).
|
|
|
Usability evaluation
Tidsram: During surgery (at the end of the procedure)
|
the AutoLap system usability in laparoscopic procedures will be assessed by a questionnaire.
The questionnaire assesses the surgeon's satisfaction with the use of the AutoLap in regard to easiness of use, convenient of movement control and its ability to be used in the OR without interfering with the surgical flow
|
During surgery (at the end of the procedure)
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 december 2012
Primärt slutförande (Faktisk)
1 juni 2014
Avslutad studie (Faktisk)
1 juni 2014
Studieregistreringsdatum
Först inskickad
3 april 2013
Först inskickad som uppfyllde QC-kriterierna
7 april 2013
Första postat (Uppskatta)
10 april 2013
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
31 december 2014
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
30 december 2014
Senast verifierad
1 december 2014
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- AL-65-001
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .